Scientific Reports (Oct 2024)

Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipids

  • Tetsuya Kuwano,
  • Takayuki Kanno,
  • Minoru Tobiume,
  • Yuichiro Hirata,
  • Harutaka Katano,
  • Michiko Koga,
  • Hiroyuki Nagai,
  • Takeya Tsutsumi,
  • Noritada Yoshikawa,
  • Hiroshi Yotsuyanagi,
  • Satoshi Kutsuna,
  • Yusuke Miyazato,
  • Noriko Kinoshita-Iwamoto,
  • Norio Ohmagari,
  • Taiichiro Kobayashi,
  • Kazuaki Fukushima,
  • Masaru Tanaka,
  • Akifumi Imamura,
  • Yui Ueda,
  • Maeko Iwamura,
  • Naoto Takada,
  • Takayoshi Inoue,
  • Tetsuro Matano,
  • Ai Kawana-Tachikawa,
  • Tadaki Suzuki

DOI
https://doi.org/10.1038/s41598-024-77862-0
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 8

Abstract

Read online

Abstract There have been several reports of skin manifestations in patients with coronavirus disease 2019 (COVID-19). However, it is unclear whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can be detected on the skin surface, including the sebum, of these patients. In this study, SARS-CoV-2 RNA was detected using real-time reverse-transcription polymerase chain reaction (RT-PCR) assay of skin surface lipids (SSLs) collected using an oil-blotting film from the faces of hospitalized patients with COVID-19. Human transcriptome analysis was also performed using the same samples. In facial SSLs of patients with COVID-19, the RT-PCR positivity rate was 84.6% (11/13 samples) within 5 days and 30.4% (7/23 samples) by 6–10 days of symptom onset. In the transcriptome analysis, the most characteristic SSL-RNA profile was the upregulation of interferon-stimulated gene (ISG)-related genes, such as ISG15, IFITM1, and MX1. This study presents an alternative technique using SSLs for non-invasive SARS-CoV-2 RNA detection and simultaneous analysis of human molecular pathogenesis in patients with COVID-19.

Keywords